1LoPachin RM, Jones RC, Patterson TA, et al. Application of Proteomics to the Study of Molecular Mechanisms in Neurotoxicology [ J ]. Neurotoxicology,2003, 24 (6) : 761 - 775.
5Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for the period 2005-2006 [ J ]. Mass Spectrom Rev,2011, 30( 1 ) : 1-100.
6Chalkley RJ, Burlingame AL. Identification of GlcNAcylation sites of peptides and alpha-crystallin using Q-TOF mass spectrometry [J] J Am Soc Mass Spectrom, 2001,12 (10) :1106-1113.
7Ma Y, Lu Y, Zheng H, et al. Characterization of phosphopeptides from protein digests using matrix assisted laser desorption/ionization time-of-flight mass spectrometry and nanoelectrospray quadrupole time-of-flight mass spectrometry[J]. Rapid Commun Mass Spectrom, 2001, 15(18) :1693-1700.
8Raman K. Construction and analysis of protein-protein interaction networks [ J ]. Autom Exp Published online, 2010, 2(1) :2.
4Riederer P,Wuketich S.Time course of nigrostriatal degeneration in Parkinson's disease.A detailed study of influential factors in human brain amine analysis[J].J Neural Transm,1976,38:277-301.
5Dotzlaw H,Schulz M,Eggert M,et al.A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals[J].Biochim Biophys Acta,2004,1696:121-129.
6Kang X,Xu Y,Wu X,et al.Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome[J].Clin Chem,2005,51:56--64.
7Stebbins G T,Goetz C G.Factor structure of the Unified Parkinson's Disease Reting Scale:Motor Examination section[J].Mov Disord,1998,13:633-636.
8Mian S,Ugurel S,Parkinson E,et al.Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients[J].J Clin Oncol,2005,23:5088-5093.
9Varghese S A,Powell T B,Budisavljevic M N,et al.Urine hiomarkers predict the cause of glomerular disease[J].J Am Soc Nephrol,2007,18:913-922.
10Gasser T.Genetics of Parkinson's disease[J].Curr Opin Neurol,2005,18:363-369.
5Evans HL. Markers of neurotoxicity: from behavior to autoantibodies against brain proteins [J]. Clin Chem, 1995, 41(12 Pt2): 1874-1881.
6Ragin AB, Wu Y, Ochs R, et al. Biomarkers of neurological status in HIV infection: A three year study[J].Proteomics Clin Appl, 2010, 4(3):295-303.
7Marreilha Dos Santos AP, Lopes Santos M, Batoreu MC, et al. Prolactin is a peripheral marker of manganese neurotoxicity[J]. Brain Res, 2011, 1382: 282-290.
8Costa LG. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations[J]. Environ Health Perspect, 1996, 104(1): 55-67.
